ConductScience.org, home

Trial · NCT03470441

Outcomes19

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYArrhythmias of Interest, 48 Hours (Overall)First 48 hours post-treatmentparticipantsNUMBER
PRIMARYArrhythmias of Interest Incidence Rate, 48 Hours (Overall)48 hours post-treatmentPercentageNUMBER
PRIMARYArrhythmias of Interest, 14 Days (Overall)48 hours to 14 days Post Percutaneous Coronary Intervention (PCI)participantsNUMBER
PRIMARYArrhythmias of Interest Incidence Rate, 14 Days (Overall)48 hours to 14 days Post Percutaneous Coronary Intervention (PCI)PercentageNUMBER
SECONDARYInfarct Size Relative to Ventricular Volume, 72 Hours (Overall)72 hours post-treatmentINF/VV (%)MEDIAN
SECONDARYInfarct Size Relative to Ventricular Volume, 3 Months (Overall)3 months post-treatmentINF/VV (%)MEDIAN
SECONDARYInfarct Size Relative to Ventricular Volume, 72 Hours (Anterior Infarcts)72 hours post-treatmentINF/VV (%)MEDIAN
SECONDARYInfarct Size Relative to Ventricular Volume, 3 Months (Anterior Infarcts)3 months post-treatmentINF/VV (%)MEDIAN
SECONDARYLeft Ventricular End Systolic Volume Index, 72 Hours (Overall)72 hours post-treatmentmL/kg/M2MEDIAN
SECONDARYLeft Ventricular End Systolic Volume Index, 3 Months (Overall)3 months post-treatmentmL/kg/M2MEDIAN
SECONDARYLeft Ventricular End Systolic Volume Index, 72 Hours (Anterior Infarcts)72 hours post-treatmentmL/kg/M2MEDIAN
SECONDARYLeft Ventricular End Systolic Volume Index, 3 Months (Anterior Infarcts)3 months post-treatmentmL/kg/M2MEDIAN
SECONDARYLeft Ventricular Ejection Fraction, 72 Hours (Overall)72 hours post-treatmentPercentageMEDIAN
SECONDARYLeft Ventricular Ejection Fraction, 3 Months (Overall)3 months post-treatmentPercentageMEDIAN
SECONDARYLeft Ventricular Ejection Fraction, 72 Hours (Anterior Infarcts)72 hours post-treatmentPercentageMEDIAN
SECONDARYLeft Ventricular Ejection Fraction, 3 Months (Anterior Infarcts)3 months post-treatmentPercentageMEDIAN
SECONDARYSerum Troponin Concentrations, 48 Hours (Overall)48 hours post-treatmentAUC4-48 µg/LMEDIAN
SECONDARYSerum Troponin Concentrations, 48 Hours (Anterior Infarcts)48 hours post-treatmentAUC4-48 µg/LMEDIAN
SECONDARYST-segment Resolution4 hours post-dosepercentageNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03470441/outcomes